Lord, Abbett & Co’s Surmodics SRDX Stock Holding History

Lord, Abbett & Co’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-139,600	Closed	-$2.79M	–	1096
2013 Q2	$2.79M	Buy	+139,600	New	+$3.49M	0.01%	903

Other funds holding SRDX

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lord, Abbett & Co's SRDX Position: Q3 2013 in Review

Lord, Abbett & Co sold out of Surmodics (SRDX) in Q3 2013, closing a stake of 139,600 shares — an estimated $2.79M sold.

Lord, Abbett & Co first reported a position in SRDX in Q2 2013 and held it in 1 quarter. The position peaked at $2.79M in Q2 2013. 114 funds tracked by Wall St. Rank hold SRDX as of Q3 2013.

Lord, Abbett & Co reported no remaining Surmodics position as of Q3 2013 after selling out during the quarter.
Lord, Abbett & Co sold 139,600 Surmodics shares in Q3 2013, an estimated $2.79M.
Lord, Abbett & Co first reported a position in Surmodics in Q2 2013 and held it in 1 quarter.
Lord, Abbett & Co's Surmodics position peaked at $2.79M in Q2 2013.
114 funds tracked by Wall St. Rank held Surmodics as of Q3 2013.

Based on Lord, Abbett & Co's 13F filing for Q3 2013, filed 14 Nov 2013.